Reliable surrogate outcome measures in multicenter clinical trials of Duchenne muscular dystrophy

Jill E. Mayhew, Julaine M. Florence, Thomas P. Mayhew, Erik K Henricson, Robert T. Leshner, Robert J. McCarter, Diana M. Escolar

Research output: Contribution to journalArticle

85 Citations (Scopus)

Abstract

We studied the reliability of a series of endpoints in an evaluation of subjects with Duchenne muscular dystrophy (DMD). The endpoints included quantitative muscle tests (QMTs), timed function tests, forced vital capacity (FVC), and manual muscle tests (MMT). Thirty-one ambulatory subjects with DMD (mean age 8.9 years; range 5-16 years) were evaluated at eight sites by 15 newly trained evaluators as a test of interrater reliability of outcome measures. Both total QMT score [intraclass correlation coefficient (ICC) 0.96] and individual QMT assessments (ICC 0.85-0.96) were highly reliable. Forced vital capacity and all timed function tests were also highly reliable (ICC 0.97-0.99). MMT was the least reliable assessment method (ICC 0.61). These data suggest that primary surrogate outcome measures in large multicenter clinical trials in DMD should use QMT, FVC, or time function tests to obtain maximum power and greatest sensitivity.

Original languageEnglish (US)
Pages (from-to)36-42
Number of pages7
JournalMuscle and Nerve
Volume35
Issue number1
DOIs
StatePublished - Jan 2007
Externally publishedYes

Fingerprint

Duchenne Muscular Dystrophy
Multicenter Studies
Outcome Assessment (Health Care)
Clinical Trials
Muscles
Vital Capacity
Forced Expiratory Volume

Keywords

  • Duchenne muscular dystrophy
  • Interrater reliability
  • Pediatric neuromuscular testing
  • Quantitative muscle testing (QMT)

ASJC Scopus subject areas

  • Physiology
  • Clinical Neurology
  • Cellular and Molecular Neuroscience
  • Physiology (medical)

Cite this

Mayhew, J. E., Florence, J. M., Mayhew, T. P., Henricson, E. K., Leshner, R. T., McCarter, R. J., & Escolar, D. M. (2007). Reliable surrogate outcome measures in multicenter clinical trials of Duchenne muscular dystrophy. Muscle and Nerve, 35(1), 36-42. https://doi.org/10.1002/mus.20654

Reliable surrogate outcome measures in multicenter clinical trials of Duchenne muscular dystrophy. / Mayhew, Jill E.; Florence, Julaine M.; Mayhew, Thomas P.; Henricson, Erik K; Leshner, Robert T.; McCarter, Robert J.; Escolar, Diana M.

In: Muscle and Nerve, Vol. 35, No. 1, 01.2007, p. 36-42.

Research output: Contribution to journalArticle

Mayhew, JE, Florence, JM, Mayhew, TP, Henricson, EK, Leshner, RT, McCarter, RJ & Escolar, DM 2007, 'Reliable surrogate outcome measures in multicenter clinical trials of Duchenne muscular dystrophy', Muscle and Nerve, vol. 35, no. 1, pp. 36-42. https://doi.org/10.1002/mus.20654
Mayhew, Jill E. ; Florence, Julaine M. ; Mayhew, Thomas P. ; Henricson, Erik K ; Leshner, Robert T. ; McCarter, Robert J. ; Escolar, Diana M. / Reliable surrogate outcome measures in multicenter clinical trials of Duchenne muscular dystrophy. In: Muscle and Nerve. 2007 ; Vol. 35, No. 1. pp. 36-42.
@article{22b2153af8104564878d1ca374a98f49,
title = "Reliable surrogate outcome measures in multicenter clinical trials of Duchenne muscular dystrophy",
abstract = "We studied the reliability of a series of endpoints in an evaluation of subjects with Duchenne muscular dystrophy (DMD). The endpoints included quantitative muscle tests (QMTs), timed function tests, forced vital capacity (FVC), and manual muscle tests (MMT). Thirty-one ambulatory subjects with DMD (mean age 8.9 years; range 5-16 years) were evaluated at eight sites by 15 newly trained evaluators as a test of interrater reliability of outcome measures. Both total QMT score [intraclass correlation coefficient (ICC) 0.96] and individual QMT assessments (ICC 0.85-0.96) were highly reliable. Forced vital capacity and all timed function tests were also highly reliable (ICC 0.97-0.99). MMT was the least reliable assessment method (ICC 0.61). These data suggest that primary surrogate outcome measures in large multicenter clinical trials in DMD should use QMT, FVC, or time function tests to obtain maximum power and greatest sensitivity.",
keywords = "Duchenne muscular dystrophy, Interrater reliability, Pediatric neuromuscular testing, Quantitative muscle testing (QMT)",
author = "Mayhew, {Jill E.} and Florence, {Julaine M.} and Mayhew, {Thomas P.} and Henricson, {Erik K} and Leshner, {Robert T.} and McCarter, {Robert J.} and Escolar, {Diana M.}",
year = "2007",
month = "1",
doi = "10.1002/mus.20654",
language = "English (US)",
volume = "35",
pages = "36--42",
journal = "Muscle and Nerve",
issn = "0148-639X",
publisher = "John Wiley and Sons Inc.",
number = "1",

}

TY - JOUR

T1 - Reliable surrogate outcome measures in multicenter clinical trials of Duchenne muscular dystrophy

AU - Mayhew, Jill E.

AU - Florence, Julaine M.

AU - Mayhew, Thomas P.

AU - Henricson, Erik K

AU - Leshner, Robert T.

AU - McCarter, Robert J.

AU - Escolar, Diana M.

PY - 2007/1

Y1 - 2007/1

N2 - We studied the reliability of a series of endpoints in an evaluation of subjects with Duchenne muscular dystrophy (DMD). The endpoints included quantitative muscle tests (QMTs), timed function tests, forced vital capacity (FVC), and manual muscle tests (MMT). Thirty-one ambulatory subjects with DMD (mean age 8.9 years; range 5-16 years) were evaluated at eight sites by 15 newly trained evaluators as a test of interrater reliability of outcome measures. Both total QMT score [intraclass correlation coefficient (ICC) 0.96] and individual QMT assessments (ICC 0.85-0.96) were highly reliable. Forced vital capacity and all timed function tests were also highly reliable (ICC 0.97-0.99). MMT was the least reliable assessment method (ICC 0.61). These data suggest that primary surrogate outcome measures in large multicenter clinical trials in DMD should use QMT, FVC, or time function tests to obtain maximum power and greatest sensitivity.

AB - We studied the reliability of a series of endpoints in an evaluation of subjects with Duchenne muscular dystrophy (DMD). The endpoints included quantitative muscle tests (QMTs), timed function tests, forced vital capacity (FVC), and manual muscle tests (MMT). Thirty-one ambulatory subjects with DMD (mean age 8.9 years; range 5-16 years) were evaluated at eight sites by 15 newly trained evaluators as a test of interrater reliability of outcome measures. Both total QMT score [intraclass correlation coefficient (ICC) 0.96] and individual QMT assessments (ICC 0.85-0.96) were highly reliable. Forced vital capacity and all timed function tests were also highly reliable (ICC 0.97-0.99). MMT was the least reliable assessment method (ICC 0.61). These data suggest that primary surrogate outcome measures in large multicenter clinical trials in DMD should use QMT, FVC, or time function tests to obtain maximum power and greatest sensitivity.

KW - Duchenne muscular dystrophy

KW - Interrater reliability

KW - Pediatric neuromuscular testing

KW - Quantitative muscle testing (QMT)

UR - http://www.scopus.com/inward/record.url?scp=33845989867&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=33845989867&partnerID=8YFLogxK

U2 - 10.1002/mus.20654

DO - 10.1002/mus.20654

M3 - Article

C2 - 16969838

AN - SCOPUS:33845989867

VL - 35

SP - 36

EP - 42

JO - Muscle and Nerve

JF - Muscle and Nerve

SN - 0148-639X

IS - 1

ER -